SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Liabilities | ₹2,169 Cr | ₹333 Cr | ₹514 Cr | ₹830 Cr |
What is the latest Total Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹2,169 Cr |
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹514 Cr |
| Mar2023 | ₹830 Cr |
How is Total Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,169 Cr | 550.79 | |
| Mar2025 | ₹333 Cr | -35.14 | |
| Mar2024 | ₹514 Cr | -38.11 | |
| Mar2023 | ₹830 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,756.1 Cr | 0.4% | -21.3% | 42.4% | Stock Analytics | |
| PRIME FOCUS | ₹22,101.6 Cr | -6.3% | 11% | 96.2% | Stock Analytics | |
| SAGILITY | ₹20,410.6 Cr | -1.1% | 2.6% | -2.9% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,253.7 Cr | -1.1% | -4.2% | -42.6% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,307.1 Cr | -1.3% | 2.1% | -4.5% | Stock Analytics | |
| INDEGENE | ₹13,695.2 Cr | 2.6% | 11.6% | -3.9% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 0.4% |
-21.3% |
42.4% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses